Friday, July 14, 2006

Xencor Gets $6M

Monrovia-based Xencor has received $6M in a bridge financing deal, the firm said this week. Xencor said that the funding came from Novo Nordisk and existing investors, including Zen Investments. Xencor also said that Novo Nordisk has committed to invest an additional $6M in future financings. Xencor is developing protein and antibody therapeutics. The funding brings the firm's total raised to over $90M. More information »